Raymond James Financial Services Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

Raymond James Financial Services Advisors’s Portfolio TARS Stock Details TARS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$341K	Sell
2024 Q2	$354K	Sell
2024 Q1	$1.85M	Buy
2023 Q4	$887K	Buy
2023 Q3	$545K	Buy
2023 Q2	$305K	Buy